ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,235.30
-0.54%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
-0.01%
Brent Oil
72.72
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Aura Biosciences Inc (AURA) 銘柄情報

Aura Biosciences Inc

Aura Biosciences Inc (AURA)

Aura Energy Limited
8.20
0.09
(1.11%)
終了 12月22日 6:00AM
15分遅延
8.2005
0.0005
(0.01%)
取引時間後: 9:59AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
8.20
買値
7.12
売値
13.20
出来高
612,493
8.01 日の範囲 8.43
6.63 52 週間の範囲 12.3782
時価総額
409.602M
前日終値
8.11
始値
8.03
時刻
623
@
8.2
(priorref)
最終取引時間
財務取引量
US$ 4,982,809
VWAP
8.1353
平均取引量 (3 か月)
202,202
発行済株式数
49,951,466
配当利回り
-
PER
-5.37
1 株当たり利益 (EPS)
-1.53
歳入
-
純利益
-76.41M

Aura Biosciences Inc について

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
www.aurabiosciences.com
本社
Wilmington, Delaware, USA
設立
-
Aura Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker AURA. The last closing price for Aura Biosciences was US$8.11. Over the last year, Aura Biosciences shares have traded in a share price range of US$ 6.63 to US$ 12.3782.

Aura Biosciences currently has 49,951,466 shares in issue. The market capitalisation of Aura Biosciences is US$405.11 million. Aura Biosciences has a price to earnings ratio (PE ratio) of -5.37.

AURA 最新ニュース

その他のニュース

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

BOSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ...

2024年11月26日
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月19日
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

2024年11月19日
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2024年11月15日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月13日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月13日
Edgar (US Regulatory)

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...

2024年11月13日
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

2024年11月9日
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

2024年10月30日
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

2024年10月30日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.18-2.147971360388.389.048.0252151628.47804317CS
4-0.82-9.090909090919.029.538.0251924678.70404999CS
12-0.96-10.4803493459.1612.37828.0252022029.77877856CS
261.1315.98302687417.0712.37826.631920409.14070888CS
52-0.55-6.285714285718.7512.37826.631791878.52910211CS
156-7.17-46.64931685115.3724.835.9912359410.15983231CS
260-5.9-41.843971631214.126.165.9912688810.66362821CS

AURA - Frequently Asked Questions (FAQ)

What is the current Aura Biosciences share price?
The current share price of Aura Biosciences is US$ 8.20
How many Aura Biosciences shares are in issue?
Aura Biosciences has 49,951,466 shares in issue
What is the market cap of Aura Biosciences?
The market capitalisation of Aura Biosciences is USD 405.11M
What is the 1 year trading range for Aura Biosciences share price?
Aura Biosciences has traded in the range of US$ 6.63 to US$ 12.3782 during the past year
What is the PE ratio of Aura Biosciences?
The price to earnings ratio of Aura Biosciences is -5.37
What is the reporting currency for Aura Biosciences?
Aura Biosciences reports financial results in USD
What is the latest annual profit for Aura Biosciences?
The latest annual profit of Aura Biosciences is USD -76.41M
What is the registered address of Aura Biosciences?
The registered address for Aura Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aura Biosciences website address?
The website address for Aura Biosciences is www.aurabiosciences.com
Which industry sector does Aura Biosciences operate in?
Aura Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

議論

フィード全体を表示

最近閲覧した銘柄

NASDAQ
AURA
Aura Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有